Clinical Trial: Study of Radiotherapy Combined With Platinum, Adebrelimab and Bevazumab in the Treatment of TNBC-BM.

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07638852) titled 'Study of Radiotherapy Combined With Platinum, Adebrelimab and Bevazumab in the Treatment of TNBC-BM.' on Jan. 26.

Brief Summary: This is an open-label, prospective, single-arm, multicenter phase II clinical trial. The aim is to explore the efficacy and safety of radiotherapy combined with cisplatin/carboplatin, adebrelimab, and bevacizumab in patients with triple-negative breast cancer and brain metastases.

Study Start Date: Feb. 23

Study Type: INTERVENTIONAL

Condition: TNBC, Triple Negative Breast Cancer Brain Metastasases

Intervention: DRUG: Radiotherapy followed by systemic therapy

Radiotherapy followed by Adebrelimab+Beva...